MDM2 oncogene inhibition;steady and sustained release ;improvement on cancer cell uptake in vitro, tumor uptake in vivo, oral bioavailability, absorption, half-life and anticancer efficacy;little toxicity in mice at high doses. The gene discussed is MDM2; the disease is cancer.